📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial. (2018)

First Author: O'Leary B

Attributed to: MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-18-0264

PubMed Identifier: 30206110

Publication URI: http://europepmc.org/abstract/MED/30206110

Type: Journal Article/Review

Volume: 8

Parent Publication: Cancer discovery

Issue: 11

ISSN: 2159-8274